Translational control by ketamine and its implications for comorbid cognitive deficits in depressive disorders. Lewis V, Rodrigue B, Arsenault E, Zhang M, et al. J Neurochem 2023;166:10-23.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lewis V, Rodrigue B, Arsenault E, Zhang M, et al. Translational control by ketamine and its implications for comorbid cognitive deficits in depressive disorders. J Neurochem 2023;166:10-23.
PMID: 35680556